Metaplanet will implement a 10-for-1 stock split on April 1, reducing the per-share price to improve market liquidity.

Windtree Therapeutics, Inc. (NasdaqCM: WINT) (“Windtree” or the “Company”), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

The Supreme Court said an arbitral tribunal has jurisdiction over the husband in cases under Bye-law 248(a) of the Bombay ...

Méliuz reported that Banco BV chose not to exercise the share purchase after a preliminary discussion regarding the terms of ...

She unloaded over 65% of her shares and options in the past 12 months, yielding $168 million before taxes–benefitting from the stock’s spike following President Donald Trump’s election ...

What Happened: Joshua, Vice President at T. Rowe Price Gr, made a strategic move by exercising stock options for 1,419 shares of TROW as detailed in a Form 4 filing on Wednesday with the U.S.

A significant insider transaction involving the exercise of company stock options was reported on February 12, by Nelson, Joshua, Vice President at T. Rowe Price Gr (NASDAQ:TROW), as per the ...

What Happened: Morrow, Board Member at Lantheus Holdings, made a strategic move by exercising stock options for 0 shares of LNTH as detailed in a Form 4 filing on Wednesday with the U.S. Securities ...

Moleculin Biotech, Inc. filed a Form 8-K with the Securities and Exchange Commission, announcing the company’s entry into a warrant exercise inducement offer letter. The letter, which was signed with ...

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ...

Debt-laden Quantum Corporation posts improved Q3 FY2025 results but plans $200M equity sale. Click here to find out why QMCO ...